Status:
COMPLETED
Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.
Lead Sponsor:
Sonova AG
Collaborating Sponsors:
State University of New York at Buffalo
Conditions:
Hearing Loss, Sensorineural
Tinnitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Participants with hearing loss and Tinnitus will wear hearing aids with amplification-only or with an added sound, and have their tinnitus level evaluated before and after intervention.
Detailed Description
2 groups of adults with hearing loss and chronic bothersome tinnitus and no experience with amplification will participate in a cross over intervention study with 2 conditions of 4 weeks each: 1. fit ...
Eligibility Criteria
Inclusion
- Hearing loss
- candidate for hearing aid amplification
- Bothersome chronic tinnitus (3 months+)
Exclusion
- age less than 18 years
- normal hearing
- tinnitus presence for less than 3 months
- tinnitus not bothersome enough to warrant intervention
- non hearing aid candidates
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 20 2023
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT05292534
Start Date
June 1 2022
End Date
September 20 2023
Last Update
July 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The State University of New York at Buffalo
Buffalo, New York, United States, 14203